Departments
Radiation Oncology
Radiation Oncology
External radiotherapy
Volumetric Modulated Arc Therapy (VMAT)
Image Guided Radiation Therapy (IGRT)
Intensity Modulated Radiation Therapy (IMRT)
Stereotactic Radiation Therapy (SRT)
Stereotactic Radio Surgery (SRS)
Stereotactic Body Radiation Therapy (SBRT)
Three-Dimensional Conformal Radiation Therapy (3-D CRT)
Respiratory Gating
Internal Radiotherapy
Remote After Loading High Dose Rate Brachytherapy (HDR Brachytherapy)
Medical Oncology
Medical Oncology
Chemotherapy
Hormonal Therapy
Immunotherapy / Biological Therapy
Targeted Therapy
Neutropenic Care
Nutritional Therapy
Surgical Oncology
Surgical Oncology
Neuro Oncology
Head and Neck Oncology
Breast Oncology
Thoracic Oncology
Gynaec Oncology
Cosmetic and Reconstructive Surgery
G. I. Oncology
Uro Oncology
Musculo-skeletal Oncology
Gynaec Oncology
Gynaec Oncology
Cancer of Cervix
Cancer of Ovary and Fallopian Tube
Cancer of Uterine Cavity
Cancer of Vulva
Cancer of vagina
Cancer of Persistent Gestational Trophoblastic Tumor (GTNs)
Anesthesiology & Critical
Radiology & Imaging
Pathology & Transfusion
Pathology & Transfusion
Histopathology
Cytopathology
Haematology
Biochemistry
Serology
Clinical Pathology
Microbiology
Transfusion Medicine
Emergency Services
Nursing Services
Our Doctors

- Featured Doctors in Popular Specialties.... ........ Read more
Cancer of Uterine Cavity
Incidence- It is commonest genital tract malignancy among women of in western countries. In United States about 41,200 new cases registered every year.
- Its incidence in India the is on the rise mainly because of the changes in the lifestyle & obesity.
- In population based cancer registry of Delhi, the incidence of endometrial cancer is 4.3/ 100,000 women per year (ICMR).
- >70% of cases, are confined to uterus at time of diagnosis
Predisposing high risk Factors
- Most uterine cancers develop at age >50years , but 10% of them are in <40 yrs of age.
- Exposure to unopposed estrogen; ERT, anovulatory cycles/infertility, obesity, estrogen secreting tumors.
- Tamoxifen exposure increases risk to 2-3 folds.
- Family history of uterine, breast, ovarian or colorectal cancers.
- Occasionally may develop post radiation for cancer cervix.
Presenting Features
- Abnormal vaginal bleeding in 90% cases, especially if in postmenopausal women
- Abnormal inter-menstrual or heavy prolonged peri-menopausal bleeding
- Some may present with purulent vaginal discharge
- High index of suspicion is necessary to diagnose it in young women, who has history of PCOD/ anovulatory cycles
- Abnormality in pap smear
Staging of Uterine Cancers
- Stage I: In this stage the cancer is limited to the uterus
- Stage II: In this stage the cancer spread to the cervix area of the uterus
- Stage III: In this stage, cancer reached an advanced phase but it is still located only in the pelvis
- Stage IV: In this stage, the cancer spreads massively to the entire pelvic cavity or affected distant organs and areas
Diagnosis
- Pelvic sonography
- Endometrial sampling by EB or D&C
Treatment
- Surgery: Staging laparotomy:- Total hysterectomy with BSO with lymph node dissection upto para-aortic lymph nodes, followed by adjuvant tailored radiotherapy. Sometimes hormonal therapy or chemotherapy may also be required.
Prognosis
- 5 year survival rate varies with histo-pathological type of tumor
- Endometriod type variety of uterus is highly treatable cancer in early stages and fortunately most cases(>70% ) are diagnosed, when confined is still to uterus( Stage I ).
- Survival rates are lower in other varieties like uterine papillary serous or sarcomatous or mixed mullerian types

Follow us on